Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis

Exclusion Criteria

• •Contraindication for the use of the study medication or other beta-lactam antibiotics, e.g. patients with advanced renal impairment or patients requiring hemodialysis
• •Antibiotic therapy in the two weeks prior to the start of the study
• •Patients with an advanced incurable disease
• •Patients with a hematologic/oncologic disease (leukemia, lymphoma)
• •Patients on immunosuppressants
• •Complications of sigmoid diverticulitis leading to an immediate indication for surgery
• •Patients who have hypersensitivity to beta-lactam antibiotics
• •Female patients who are pregnant or nursing or who could become pregnant during the study
• •Participation in another clinical study or use of another study drug within the four weeks prior to enrollment in the study or use of another drug during the study
• •Each patient can be enrolled only once in the study